查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678521

气雾剂给药装置市场规模、份额、趋势分析报告：按类型、应用、分销管道、地区和细分市场预测，2025-2030 年

Aerosol Drug Delivery Devices Market Size, Share & Trends Analysis Report By Type (Inhaler, Nebulizer), By Application (COPD, Asthma, Cystic Fibrosis), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

气雾剂给药装置市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球气雾剂药物输送设备市场预计到 2030 年将达到 621 亿美元。

预计 2025 年至 2030 年间，市场将以 13.16% 的显着复合年增长率扩张。推动市场成长的关键因素包括呼吸系统疾病盛行率的上升、医疗意识的增强、吸入器技术的进步以及家庭治疗的需求不断增长。

市场成长的动力在于慢性阻塞性肺病、气喘和囊肿纤维化等呼吸系统疾病的盛行率不断上升，对携带式吸入设备的关注度不断提高，以及对快速有效治疗的需求。其他因素包括政府宣传宣传活动、人口老化、技术进步、设备采用率提高、都市化、污染、研发增加。

进入市场的创新专注于开发环保燃料、改进用户介面设计以提高患者依从性以及利用人工智慧进行个人化诊断和治疗。生物分解性材料的研究可能为设备建造提供可持续的替代方案。市场竞争激烈且分散，技术的快速进步推动着不断的变化。公司正积极顺应潮流，透过专注于以患者为中心和环保的解决方案来抓住成长机会。

此外，阿普塔集团 (AptarGroup, Inc.)、荷兰皇家飞利浦公司 (Koninklijke Philips NV)、阿斯特捷利康 (AstraZeneca) 和诺华公司 (Novartis AG) 等主要企业正在采取合作、研究合作、新产品发布、收购和业务扩展等战略倡议，以加强其市场地位。例如，2024年1月，Kindeva Drug Delivery宣布收购专门从事鼻腔给药的公司Summit Biosciences。

鼻腔给药正在成为许多适应症的首选给药方式，因为它允许在急性和紧急情况下进行非侵入性药物给药。 高峰会对如何有效配製鼻腔给药药物以及进行商业规模生产的能力有着独特的理解。此次收购不仅符合 Kindeva 成为药物-设备组合 CDMO 市场全球领导者的雄心，而且还扩展了公司可为全球客户提供的工具箱，以帮助改善患者的治疗效果和治疗体验。

Kindeva 执行长 Milton Boyer

气雾剂药物输送设备市场报告重点

  • 根据产品类型，吸入器市场预计将在 2024 年占据市场主导地位，收益占有率为 89.59%，并且预计在预测期内以最快的复合年增长率增长，这得益于技术先进产品的不断发展和医疗保健领域数字解决方案的不断采用。
  • 根据应用，COPD 领域预计将在 2024 年占据最大的市场占有率，并且由于全球盛行率上升，预计在预测期内将增长最快。
  • 根据分销管道，由于大宗药品分销需求的不断增长和呼吸系统疾病患者人数的不断增加，机构药房部门将在 2024 年占据最大的市场占有率。
  • 北美占据气雾剂药物输送设备产业的主导地位，2024 年的市场占有率为 39.49%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章。气雾剂药物输送装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 产业分析
    • 使用者观点分析
    • 主要最终用户
  • 技术展望
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战与机会分析
  • 气雾剂给药装置市场分析工具
    • 波特的分析
    • PESTEL 分析
  • COVID-19 的影响

4. 气雾剂给药装置市场类型、估计与趋势分析

  • 定义和范围
  • 2024 年及 2030 年按类型分類的市场占有率分析
  • 细分仪表板
  • 2018 年至 2030 年气雾剂给药装置市场（按类型）
    • 喷雾器
    • 吸入器

5. 气雾剂给药装置市场：按应用分類的估计和趋势分析

  • 定义和范围
  • 2024 年和 2030 年应用市场占有率分析
  • 细分仪表板
  • 气雾剂给药装置市场（按应用划分），2018 年至 2030 年
    • 气喘
    • 慢性阻塞性肺病（COPD）

6. 气雾剂给药装置市场按分销管道分類的预测和趋势分析

  • 定义和范围
  • 2024 年及 2030 年通路市场占有率分析
  • 细分仪表板
  • 2018 年至 2030 年气雾剂给药装置市场（依通路划分）
    • 零售药局
    • 医疗机构药房
    • 网路药局

第七章气雾剂给药装置市场：区域、类型、应用和分销管道估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概况
  • SWOT 分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 气雾剂药物输送设备市场占有率（按地区划分），2024 年和 2030 年，百万美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势及影响分析
  • 公司分类
  • 公司市场占有率分析
  • 公司热图分析
  • 战略地图
    • 扩张
    • 合併和收购
    • 伙伴关係和合作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • AptarGroup, Inc.
    • Koninklijke Philips NV
    • AstraZeneca
    • Novartis AG
    • Sanofi
    • OMRON Corporation
    • Medline Industries, LP.
    • GF Health Products, Inc.
    • DRIVE MEDICAL GMBH & CO. KG
    • Teva Pharmaceutical Industries Ltd
    • Aerogen（Stamford Devices Limited Group）
    • Sensirion AG
    • PARI Respiratory Equipment, Inc.
    • Catalent, Inc
    • Pfizer Inc.
    • Beurer GmbH
Product Code: GVR-4-68040-505-5

Aerosol Drug Delivery Devices Market Growth & Trends:

The global aerosol drug delivery devices market size is anticipated to reach USD 62.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 13.16% from 2025 to 2030. Major factors driving the market growth include the rising prevalence of respiratory diseases, increasing healthcare awareness, advancements in inhaler technology, and the growing demand for home-based treatments.

The market growth is driven by the increasing prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, a growing focus on portable inhalation devices, and the need for quick, effective treatments. Other factors include government awareness campaigns, an aging population, technological advancements, higher device adoption, urbanization, pollution, and increased R&D.

Innovation in the market focuses on developing eco-friendly fuels, improving user-interface designs for better patient adherence, and using AI for personalized diagnostics and treatment. Research into biodegradable materials could provide sustainable alternatives for device construction. The market is competitive and fragmented, with rapid technological progress driving constant change. Companies proactively embrace trends, focusing on patient-centered, environmentally friendly solutions to seize growth opportunities.

Moreover, key players in the market, such as AptarGroup, Inc., Koninklijke Philips N.V., AstraZeneca, and Novartis AG, among others, are engaging in strategic initiatives such as partnerships, collaborations, new product launches, acquisitions, and expansions to strengthen their market position. For instance, in January 2024, Kindeva Drug Delivery announced the acquisition of Summit Biosciences, a company specializing in intranasal drug delivery.

"Nasal drug delivery is becoming a preferred dosage format for a growing number of indications, as it allows users to non-invasively administer medications in an acute or emergency setting. Summit brings a differentiated understanding of how to effectively formulate drugs for nasal delivery and the capability to manufacture them at commercial scale. This addition not only fits Kindeva's ambition to be a global leader in the drug-device combination products CDMO market but also expands the toolbox we can offer our customers to help improve patient outcomes and experience of care globally."

Kindeva CEO Milton Boyer.

Aerosol Drug Delivery Devices Market Report Highlights:

  • Based on type, the inhaler segment dominated the market with a revenue share of 89.59% in 2024 and is expected to witness the fastest growth at a CAGR over the forecast period owing to the advancement the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector.
  • Based on application, the COPD segment held the largest market share in 2024 and is anticipated to be the fastest-growing segment over the forecast period owing to the rising increasing prevalence worldwide.
  • Based on the distribution channel, the institutional pharmacies segment held the largest market share in 2024, driven by the increasing need for bulk medication distribution, and the expanding patient population with respiratory conditions.
  • North America dominated the aerosol drug delivery devices industry with a market share of 39.49% in 2024, owing to the advanced healthcare infrastructure, increasing geriatric population, and technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
      • 1.7.1.2. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Aerosol Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Technological advancements
      • 3.5.1.3. Rising geriatric population
      • 3.5.1.4. Increasing awareness of self-medication and home healthcare
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. High cost of devices
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Aerosol Drug Delivery Devices Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal Landscape
  • 3.7. Impact of COVID-19

Chapter 4. Aerosol Drug Delivery Devices Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Aerosol Drug Delivery Devices Market: By Type, 2018 to 2030
    • 4.4.1. Nebulizers
      • 4.4.1.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. Jet
        • 4.4.1.2.1. Jet Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.3. Mesh
        • 4.4.1.3.1. Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.4. Active
        • 4.4.1.4.1. Active Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.5. Passive
        • 4.4.1.5.1. Passive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.6. Ultrasonic
        • 4.4.1.6.1. Ultrasonic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Inhaler
      • 4.4.2.1. Inhaler Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Pressurized Metered-Dose Inhaler (PMDI)
        • 4.4.2.2.1. Pressurized Metered-Dose Inhaler (PMDI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Dry-Powder Inhaler (DPI)
        • 4.4.2.3.1. Dry-Powder Inhaler (DPI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Aerosol Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Aerosol Drug Delivery Devices Market: By Application, 2018 to 2030
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 5.4.2.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Aerosol Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Aerosol Drug Delivery Devices Market: By Distribution Channel, 2018 to 2030
    • 6.4.1. Retail Pharmacies
      • 6.4.1.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Institutional Pharmacies
      • 6.4.2.1. Institutional Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Aerosol Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Region, Type, Application, Distribution Channel

  • 7.1. Definition and Scope
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Regional Market Snapshot
  • 7.5. SWOT Analysis
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. Aerosol Drug Delivery Devices Market Share, By Region, 2024 & 2030, USD Million
  • 7.7. North America
    • 7.7.1. North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Mexico
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.4.3. Competitive Insights
      • 7.7.4.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Europe
    • 7.8.1. Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. UK
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. France
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. France Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.6.3. Competitive Insights
      • 7.8.6.4. Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.7. Sweden
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.7.3. Competitive Insights
      • 7.8.7.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.8. Denmark
      • 7.8.8.1. Key Country Dynamics
      • 7.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.8.3. Competitive Insights
      • 7.8.8.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.9. Norway
      • 7.8.9.1. Key Country Dynamics
      • 7.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.9.3. Competitive Insights
      • 7.8.9.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. China
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.2.3. Competitive Insights
      • 7.9.2.4. China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Japan
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.3.3. Competitive Insights
      • 7.9.3.4. Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. India
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.4.3. Competitive Insights
      • 7.9.4.4. India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. South Korea
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.5.3. Competitive Insights
      • 7.9.5.4. South Korea Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.6. Australia
      • 7.9.6.1. Key Country Dynamics
      • 7.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.6.3. Competitive Insights
      • 7.9.6.4. Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.7. Thailand
      • 7.9.7.1. Key Country Dynamics
      • 7.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.7.3. Competitive Insights
      • 7.9.7.4. Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.2.3. Competitive Insights
      • 7.10.2.4. Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.3. Argentina
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.3.3. Competitive Insights
      • 7.10.3.4. Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Middle East and Africa
    • 7.11.1. Middle East and Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. Key Country Dynamics
      • 7.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.2.3. Competitive Insights
      • 7.11.2.4. South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.3. Saudi Arabia
      • 7.11.3.1. Key Country Dynamics
      • 7.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.3.3. Competitive Insights
      • 7.11.3.4. Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.4. UAE
      • 7.11.4.1. Key Country Dynamics
      • 7.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.4.3. Competitive Insights
      • 7.11.4.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.5. Kuwait
      • 7.11.5.1. Key Country Dynamics
      • 7.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.5.3. Competitive Insights
      • 7.11.5.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
  • 8.6. Company Profiles
    • 8.6.1. AptarGroup, Inc.
      • 8.6.1.1. Participant's Overview
      • 8.6.1.2. Financial Performance
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Recent Developments
    • 8.6.2. Koninklijke Philips N.V.
      • 8.6.2.1. Participant's Overview
      • 8.6.2.2. Financial Performance
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Recent Developments
    • 8.6.3. AstraZeneca
      • 8.6.3.1. Participant's Overview
      • 8.6.3.2. Financial Performance
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Recent Developments
    • 8.6.4. Novartis AG
      • 8.6.4.1. Participant's Overview
      • 8.6.4.2. Financial Performance
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Recent Developments
    • 8.6.5. Sanofi
      • 8.6.5.1. Participant's Overview
      • 8.6.5.2. Financial Performance
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Recent Developments
    • 8.6.6. OMRON Corporation
      • 8.6.6.1. Participant's Overview
      • 8.6.6.2. Financial Performance
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Recent Developments
    • 8.6.7. Medline Industries, LP.
      • 8.6.7.1. Participant's Overview
      • 8.6.7.2. Financial Performance
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Recent Developments
    • 8.6.8. GF Health Products, Inc.
      • 8.6.8.1. Participant's Overview
      • 8.6.8.2. Financial Performance
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Recent Developments
    • 8.6.9. DRIVE MEDICAL GMBH & CO. KG
      • 8.6.9.1. Participant's Overview
      • 8.6.9.2. Financial Performance
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Recent Developments
    • 8.6.10. Teva Pharmaceutical Industries Ltd
      • 8.6.10.1. Participant's Overview
      • 8.6.10.2. Financial Performance
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Recent Developments
    • 8.6.11. Aerogen (Stamford Devices Limited Group)
      • 8.6.11.1. Participant's Overview
      • 8.6.11.2. Financial Performance
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Recent Developments
    • 8.6.12. Sensirion AG
      • 8.6.12.1. Participant's Overview
      • 8.6.12.2. Financial Performance
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Recent Developments
    • 8.6.13. PARI Respiratory Equipment, Inc.
      • 8.6.13.1. Participant's Overview
      • 8.6.13.2. Financial Performance
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Recent Developments
    • 8.6.14. Catalent, Inc
      • 8.6.14.1. Participant's Overview
      • 8.6.14.2. Financial Performance
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Recent Developments
    • 8.6.15. Pfizer Inc.
      • 8.6.15.1. Participant's Overview
      • 8.6.15.2. Financial Performance
      • 8.6.15.3. Product Benchmarking
      • 8.6.15.4. Recent Developments
    • 8.6.16. Beurer GmbH
      • 8.6.16.1. Participant's Overview
      • 8.6.16.2. Financial Performance
      • 8.6.16.3. Product Benchmarking
      • 8.6.16.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 4 North America aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 19 UK aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 20 UK aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Germany aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 22 Germany aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 France aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 25 France aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 France aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Italy aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 28 Italy aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 Italy aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Spain aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 31 Spain aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 32 Spain aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Sweden aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 34 Sweden aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 35 Sweden aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Denmark aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 37 Denmark aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Norway aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Norway aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Japan aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 46 Japan aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 China aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 49 China aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 50 China aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 India aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 52 India aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 India aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Australia aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 55 Australia aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 56 Australia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 59 Thailand aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Brazil aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 66 Brazil aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 67 Brazil aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 68 Argentina aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 69 Argentina aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 70 Argentina aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 MEA aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 72 MEA aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 73 MEA aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 South Africa aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 75 South Africa aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 76 South Africa aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 80 UAE aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 81 UAE aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 82 UAE aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 83 Kuwait aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 84 Kuwait aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 85 Kuwait aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Aerosol Drug Delivery Devices Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Aerosol Drug Delivery Devices- Market Size and Growth Prospects (USD Million)
  • Fig. 12 Aerosol Drug Delivery Devices Market: Industry Value Chain Analysis
  • Fig. 13 Aerosol Drug Delivery Devices Market: Market Dynamics
  • Fig. 14 Aerosol Drug Delivery Devices Market: PORTER's Analysis
  • Fig. 15 Aerosol Drug Delivery Devices Market: PESTEL Analysis
  • Fig. 16 Aerosol Drug Delivery Devices Market: Type movement analysis, 2018-2030 (USD Million)
  • Fig. 17 Aerosol Drug Delivery Devices Market Share Analysis by Type, 2024 & 2030
  • Fig. 18 Nebulizers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Jet Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Mesh Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Active Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 22 Passive Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Ultrasonic Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Inhaler Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Pressurized Metered-Dose Inhaler (PDMI) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Dry-Powder Inhaler (DPI) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Aerosol Drug Delivery Devices Market: Application movement analysis, 2018-2030 (USD Million)
  • Fig. 28 Aerosol Drug Delivery Devices Market Share Analysis by Application , 2024 & 2030
  • Fig. 29 Asthma Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Chronic Obstructive Pulmonary Disease (COPD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Cystic Fibrosis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 32 Other (Pulmonary Arterial Hypertension (PAH), etc.) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 33 Aerosol Drug Delivery Devices Market: Distribution Channel Movement Analysis, 2018-2030 (USD Million)
  • Fig. 34 Aerosol Drug Delivery Devices Market Share Analysis by Distribution Channel, 2024 & 2030
  • Fig. 35 Retail Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Institutional Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 37 Online Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 Aerosol Drug Delivery Devices Market Revenue, by Region, 2024 & 2030, (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 46 Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 47 France Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 48 Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 49 Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 50 Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 51 Denmark Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 52 Norway Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 53 Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 MEA Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key Company Categorization
  • Fig. 68 Company Market Positioning
  • Fig. 69 Key Company Market Share Analysis, 2024
  • Fig. 70 Strategic Framework